화학정보학 시장 : 제품 유형별, 용도별, 최종 용도별 - 세계 예측(2024-2032년)

Chemoinformatics market size is likely to register a 15.5% CAGR from 2024-2032 driven by the increasing demand for advanced drug discovery and development processes in the pharmaceutical industry. The integration of chemical data with information technology is enabling the efficient analysis and visualization of complex chemical information, which is crucial for identifying potential drug candidates and optimizing lead compounds. For instance, in January 2024, Deloitte introduced Atlas AI, a groundbreaking addition to its Quartz AI(TM) suite, representing a significant advancement in the fields of life sciences and healthcare.

In environmental science, chemoinformatics is used to study the impact of chemicals on ecosystems and human health, aiding in the development of safer chemicals and regulatory compliance. In materials science, it helps in the design and discovery of new materials with desired properties. The continuous advancements in computational chemistry and the growing availability of chemical data will also support the market growth.

The overall industry is classified into product type, application, end-use, and region.

Based on product type, the chemoinformatics market size from the services segment is poised to generate substantial revenue between 2024 and 2032 owing to its essential support and expertise for the implementation and optimization across various industries. Chemoinformatics services, which include consulting, custom software development, training, and data analysis, help organizations effectively integrate into their workflows for maximizing the utility and efficiency of their chemical data.

In terms of application, the chemoinformatics industry will record a significant growth rate through 2032. This is backed by the need for revolutionizing the drug discovery process through computational methods that efficiently identify potential drug candidates from vast chemical libraries. Virtual screening significantly reduces the time and cost associated with traditional laboratory-based screening methods, enabling researchers to quickly and accurately predict the biological activity of compounds.

Asia Pacific chemoinformatics market size will grow at substantial CAGR through 2032 attributed to the rapid expansion of the pharmaceutical and biotechnology sectors in China, India, and Japan. These countries are increasingly investing in drug discovery and development for leveraging to streamline processes and enhance research efficiency. Government initiatives for supporting scientific research, innovation, and digital transformation will further fuel the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing R&D activities in pharmaceutical and biotechnology industries
    • 3.2.1.2 Rising demand for personalized medicine and precision healthcare
    • 3.2.1.3 Advancements in computational technologies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Data quality and availability
    • 3.2.2.2 Algorithmic bias and interpretability
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Software
• 5.3 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Chemical analysis
  • 6.2.1 Chemical databases
  • 6.2.2 Chemometrics
  • 6.2.3 Molecular modelling
  • 6.2.4 Other chemical analysis types
• 6.3 Drug discovery and validation
• 6.4 Virtual screening
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pharmaceutical and biotechnology companies
• 7.3 Academic and research institutes
• 7.4 Contract research organizations (CROs)
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 ACD/Labs, Inc.
• 9.2 Agilent Technologies, Inc.
• 9.3 Bio-Rad Laboratories, Inc.
• 9.4 BioSolveIT GmbH
• 9.5 Cadence Molecular Sciences LLC
• 9.6 Centara
• 9.7 ChemAxon Ltd
• 9.8 Chemical Computing Group ULC
• 9.9 Collaborative Drug Discovery Inc.
• 9.10 Dassault Systemes
• 9.11 Jubilant Biosys Ltd
• 9.12 Molecular Discovery Ltd
• 9.13 OpenEye Scientific Software, Inc.
• 9.14 PerkinElmer Inc.
• 9.15 Schrodinger, Inc.
• 9.16 Scilligence